NanoString
NSTG
Performance
About NanoString
NanoString Technologies specializes in spatial biology and multiomics, offering platforms for spatial transcriptomics, proteomics, and genomics to enable tissue-wide analysis and biomarker discovery. Its GeoMx Digital Spatial Profiler, CosMx Spatial Molecular Imager, and AtoMx Spatial Informatics Platform support high-plex, single-cell imaging and spatial data analysis across FFPE and fresh tissue samples, with a focus on accelerating drug development and translational research globally. The company operates primarily in the United States, with a global customer base in life sciences and biomedical research.
Recent News
Bruker Corp (BRKR) Q1 2026 Earnings Call Transcript
Two Years on From Its Launch, How Has the UPC Impacted European Patent Litigation in the Life Sciences Sector?
10x Genomics Launches Atera, a SaaS Platform for Scalable Single‑Cell Spatial Biology
Pfizer Unveils Nanoparticle Platform to Sharpen Cancer Treatment
Recent Deals
No recent deals for this company.